2012 ARS Award Recipients

2012 YOUNG ONCOLOGIST ESSAY AWARD WINNERS

Daniela L. Buscariollo, BS
Yale University School of Medicine
Survival Outcomes in Atypical Teratoid Rhabdoid Tumor for Patients
Undergoing Radiotherapy in a Surveillance, Epidemiology, and End
Results Analysis

Peyman Kabolizadeh, MD, PhD
University of Pittsburgh Cancer Institute
Dosimetric Parameters Predictive of Acute Gastrointestinal Toxicity in
Patients With Anal Carcinoma Treated With Concurrent
Chemotherapy and Intensity-Modulated Radiation Therapy

Waleed F. Mourad, MD, MSc, PhDe
Beth Israel Medical Center
Phase I/II Feasibility and Tolerability Study of Dose Intensified Postprostatectomy
Radiation Therapy to 81 Gy

David H. A. Nguyen, MD
Maisonneuve-Rosemont Hospital, University of Montreal and British
Columbia Cancer Agency
Limited M1 Disease: A Significant Prognostic Factor for Stage IV Breast Cancer

Ting Xu, MD
The University of Texas MD Anderson Cancer Center, Central South University Institute of Clinical Pharmacology, Instituto Madrileño de Oncologia/Grupo IMO
Ethnic Difference in HSPB1 Polymorphisms and Survival in Response to Radio(chemo)therapy in Non–Small-Cell Lung Cancer

Joanna C. Yang, BA
Memorial Sloan-Kettering Cancer Center
Intensity-Modulated Radiotherapy (IMRT) With Dose-Painting to Treat Rhabdomyosarcoma

2012 YOUNG ONCOLOGIST TRAVEL GRANT WINNERS

Sanjay Aneja, BS
Yale University School of Medicine
Management of Stage I Breast Cancer for Women Under the Age of 65: The Influence of Regional Radiation Oncologist and General Surgeon Services on Treatment Choice

Zachary D. Guss, AB
Johns Hopkins University School of Medicine
Management of Pediatric Intramedullary Spinal Cord Tumors: The Johns Hopkins Hospital Experience

Adrian S. Ishkanian, MSc, MD
Princess Margaret Hospital
Global Genetic Instability as a Predictor for Outcome in Intermediate Risk Prostate Cancer

Foster Lasley, MD
Indiana University
Interim Analysis of a Phase II Trial With Stereotactic Body Radiotherapy (SBRT) in Patients With Hepatocellular Carcinoma, in the Context of Child-Pugh’s [delete ’s?]Class A Liver Cirrhosis

Anna M. Leung, MD
John Wayne Cancer Institute at St. Johns Health Center and California
Oncology Research Institute
Chemoradiotherapy for Stage II Gastric Cancer: Regional Variations in Compliance With National Comprehensive Cancer Network (NCCN) Clinical Guidelines

Matthew R. McCurdy, MD, PhD
Baylor College of Medicine, Stritch School of Medicine, Loyola University
Prognostic Factors and Treatment Response in Pediatric Diffuse Intrinsic Pontine Glioma

Mackenzie C. McGee, MD
Beaumont Health System
Significant Reduction in Beta-Amyloid Plaque Burden Following Fractionated Radiotherapy Schedule in a Murine Model: Implications for Novel Treatment of Alzheimer’s Disease

Henry S. Park, BS
Yale University School of Medicine
Have National Radiotherapy Patterns and Survival Outcomes for Skull Base Chordoma and Chondrosarcoma Changed Over Time?

Malolan S. Rajagopalan, MD
University of Pittsburgh Cancer Institute
Recommendations for Post-Mastectomy Radiation Therapy After Neoadjuvant Chemotherapy: An International Survey of Radiation Oncologists

Rameses L. Sroufe, MD
SUNY Downstate
A Population-Based Study of the Impact of Post-Mastectomy Radiation on Survival for Male Breast Cancer

 

Congratulations to ALL!

 

The 2013 Award Application will open in the Fall of 2012